Pfizer Overtakes GSK but Trails Roche in PharmaDeals’ Corp-METRx Analysis of Deal Activity

Oxford, UK 26 September 2011 - PharmaVentures, the experts in deals and alliances, announced today that Corp-METRx, the new definitive analysis on the dealmaking and financial performance of the top 12 pharmaceutical companies, is launched.

PharmaVentures engaged by Astex Pharmaceuticals to Assist in the divestment of US facility

Oxford, UK 09 September 2011 - PharmaVentures Limited, experts in deals and alliances, are pleased to announce that they have been engaged by leading drug discovery company, Astex Pharmaceuticals to seek a buyer for an established full service CMC (chemistry, manufacturing & controls) & Formulation Facility in Pleasanton, California. The engagement will utilise PharmaVentures' asset divestment expertise in the life sciences sector.

PharmaVentures engaged by Avexa to Assist in the Out-licensing of Apricitabine

Oxford, UK 12 July 2011 - PharmaVentures Limited, experts in deals and alliances, are pleased to announce that they have been engaged by Avexa Limited to seek an out-licensing partner for apricitabine (ATC), a late-stage, novel treatment for HIV infection. The engagement will utilise PharmaVentures' global transactional expertise in the healthcare and investment business sectors.

PharmaVentures Divesting More Facilities for Major Pharma Companies

Oxford UK, 28 June 2011: PharmaVentures, experts in deals and alliances, are pleased to announce that they have recently been engaged by two major pharmaceutical companies to divest three facilities in three continents.

New Industry Dynamics to Help Secure the Right Deal

Oxford, UK- June 27 2011 - PharmaDeals®, the publishing division of PharmaVentures, announced today the launch of PharmaDeals v4 Enterprise Edition, a new integrated resource with a comprehensive, searchable and interactive library of reports, articles, agreements, video, graphs and deal data. As well as access to new online content, the resource also provides users with a range of applications and tools for tracking, alerting and analysing information.

PharmaVentures Corporate Advisory appoints Ping Shek as Senior Director in Transactions

PharmaVentures today announced the appointment of Ping Shek as Senior Director in the Transactions division of Corporate Advisory working on a number of key M&A and divestment mandates in the healthcare business sector.

PharmaDeals Research Reveals Early Signs of Recovery in Pharma Industry Deal Making

Oxford, UK, 22nd February 2011: PharmaDeals® research has revealed that the early stages of recovery are now evident within pharmaceutical deal making activity. The overall number of deals in 2010 grew relative to 2009, and whilst collaborative R&D deals continue to decline in numbers and value, licensing activity is on the increase.

As Pharmaceutical Deal Making Becomes More Competitive, PharmaDeals® Resource Expands its Deal Coverage

Oxford, UK, August 19 2010: PharmaVentures, the company behind the PharmaDeals®; range of business information, announced today the expansion of its PharmaDeals Agreements coverage that includes exclusive interviews with deal makers around the world. The announcement follows major enhancement of its dedicated, market leading platform delivering deal data and information to the pharmaceutical and biotechnology sector.

Biopharma Companies Gain Financially Through Unique Targeted Access to the Financial Community

OXFORD, UK, June 7, 2010 /PRNewswire: PharmaTelevision® today announced that it is offering pharma and biotech companies the opportunity to reach key decision makers in the financial sector.

PharmaTelevision Partners with Reuters Insider to Deliver BioPharma Insight to the Global Financial Community

Oxford, UK, May 11, 2010: PharmaTelevision® announced that as of today the groundbreaking online TV channel for the BioPharma industry, is teaming up with Reuters Insider, a new interactive on-demand video platform designed to change the way financial professionals consume and distribute news, research and information.


Watch our new promotional video



PharmaVentures InSights